NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

OTC Markets · Medical Devices · USD

Vicarious Surgical Inc. (RBOT) Stock Analysis

Vicarious Surgical Inc. (RBOT) is a Medical Devices stock listed on OTC Markets and quoted in US Dollar.

RBOT

$0.04

−$0.01 (−13.33%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare RBOT with… →

RBOT Key Statistics

As of Sep 4, 2026
Trading
Open
$0.05
Previous Close
$0.05
Day's Range
0.04–0.05
52-Week Range
0.03–7.73
Volume
103.40K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.86
Valuation
Market Cap
$278.12K
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−5.69
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$50.18M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
6.48M
1-Year Return
−99.32%
Dividend and dates
Avg Volume
55.37K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

RBOT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−98.20%
2025−83.51%
2024+19.53%
2023−81.83%
2022−80.98%
2021+4.53%
2020 (partial year)+4.21%

As of September 4, 2026.

RBOT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$50.18M—
2024$0.00−$63.22M—
2023$0.00−$71.07M—
2022$0.00$5.16M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$50.97M−$50.18M—
2024$0.00—−$66.56M−$63.22M—
2023$0.00—−$80.67M−$71.07M—
2022$0.00—−$80.08M$5.16M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

RBOT Valuation vs Medical Devices Median

Median of 151 stocks
MetricRBOTMedical Devices medianvs median
Profit margin0.00%−1.69%1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Vicarious Surgical Inc. (RBOT) carries a market capitalisation of $278.12K. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 48 employees.

The most recent close on file for RBOT is $0.04, dated September 4, 2026. That is −$0.01 (−13.33%) against the previous close. Over the past 52 weeks the price has ranged from $0.03 to $7.73. The latest close sits 30% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $0.00. The same year closed with a net loss of $50.18M. Profit margin runs at 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −5.69.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

The reported beta is 1.86. Annualized volatility over the trailing 6 years is 121.35%. The trailing one-year price return is −99.32%. Measured over 5 years, that is −83.29% a year compounded.

Growth & Income

No dividend is on file for RBOT.

The strongest complete calendar year on file is 2024 at +19.53%; the weakest is 2025 at −83.51%. Of the 5 complete calendar years on file, 2 finished higher. So far in 2026 the price is −98.20%.

Peer Comparison

Vicarious Surgical Inc. (RBOT) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Vicarious Surgical Inc. RBOT $278.12K —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Vicarious Surgical Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Vicarious Surgical Inc.

Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts.

Visit website →